Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.33 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL818483 | 0.84 | DNM1 (0.40) | HTTDNM1KCNH2 | |
| SCHEMBL812220 | 0.84 | DNM1 (0.40) | HTTDNM1KCNH2 | |
| SCHEMBL28741598 | 0.84 | DNM1 (0.40) | HTTDNM1KCNH2 | |
| SCHEMBL813720 | 0.82 | DNM1 (0.39) | HTTDNM1 | |
| SCHEMBL136047 | 0.79 | HTT (0.34) | HTTL3MBTL1MCHR1 | |
| SCHEMBL31154329 | 0.79 | HTT (0.34) | HTTDNM1L3MBTL1MCHR1 | |
| SCHEMBL8569205 | 0.78 | SLC22A1 (0.50) | HTTDNM1KCNH2 | |
| SCHEMBL628541 | 0.77 | DNM1 (0.34) | HTTDNM1L3MBTL1 | |
| SCHEMBL29463888 | 0.77 | DNM1 (0.34) | HTTDNM1L3MBTL1 | |
| SCHEMBL30631954 | 0.76 | HTT (0.40) | HTTL3MBTL1MCHR1KCNH2GRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 167 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4509515-B1 | LIGAND COMPOUND, ORGANIC CHROMIUM COMPOUND, AND CATALYST COMPOSITION COMPRISING SAME | LG CHEMICAL LTD (KR) | 2026-04-29 | — | — | EP | disclosed |
| EP-4700033-A1 | LIGAND COMPOUND, ORGANIC CHROMIUM COMPOUND AND CATALYST COMPOSITION COMPRISING SAME | LG Chem, Ltd. (KR) | 2026-02-25 | — | — | EP | disclosed |
| EP-4700031-A1 | LIGAND COMPOUND, ORGANIC CHROMIUM COMPOUND, AND CATALYST COMPOSITION COMPRISING SAME | LG Chem, Ltd. (KR) | 2026-02-25 | — | — | EP | disclosed |
| EP-4685217-A1 | AQUEOUS LUBRICANT COMPOSITION | Mitsui Chemicals, Inc. (JP) | 2026-01-28 | — | — | EP | disclosed |
| US-20250381558-A1 | Ligand Compound, Organic Chromium Compound, and Catalyst Compositions Containing the Same | LG CHEM, LTD. (KR) | 2025-12-18 | — | — | US | disclosed |
| US-20250333427-A1 | Ligand Compound, Organic Chromium Compound, and Catalyst Composition Including the Same | LG CHEM, LTD. (KR) | 2025-10-30 | — | — | US | disclosed |
| EP-4043500-B1 | ETHYLENE·ALPHA-OLEFIN·NON-CONJUGATED POLYENE COPOLYMER, USE THEREOF, AND MANUFACTURING METHOD THEREOF | MITSUI CHEMICALS INC (JP) | 2025-08-13 | — | — | EP | disclosed |
| US-20250197621-A1 | THERMOPLASTIC RESIN COMPOSITION | MITSUI CHEMICALS, INC. (JP) | 2025-06-19 | — | — | US | disclosed |
| EP-3124505-B1 | ETHYLENE/ALPHA-OLEFIN COPOLYMER AND LUBRICATING OIL | MITSUI CHEMICALS INC (JP) | 2025-03-19 | — | — | EP | disclosed |
| EP-4509515-A1 | LIGAND COMPOUND, ORGANIC CHROMIUM COMPOUND, AND CATALYST COMPOSITION COMPRISING SAME | LG Chem, Ltd. (KR) | 2025-02-19 | — | — | EP | disclosed |
| US-20070100056-A1 | Process for producing thermoplastic resin composition | MITSUI CHEMICALS, INC. (JP) | 2007-05-03 | — | — | US | disclosed |
| US-20070100054-A1 | Process for producing blow molded product | MITSUI CHEMICALS, INC. (JP) | 2007-05-03 | — | — | US | disclosed |
| US-20070080483-A1 | Process for producing injection molded product | MITSUI CHEMICALS, INC. (JP) | 2007-04-12 | — | — | US | disclosed |
| US-20070082998-A1 | Process for producing injection molded product | MITSUI CHEMICALS, INC. (JP) | 2007-04-12 | — | — | US | disclosed |
| EP-1731533-A1 | PROCESS FOR PRODUCING OLEFIN POLYMER | Mitsui Chemicals, Inc. (JP) | 2006-12-13 | — | — | EP | disclosed |
| US-20060270812-A1 | Copolymerizing ethylene is solution at 120-300 degrees C., with a diarylmethylene- or diarylsilylene-bridged metallocene catalyst and an organoaluminum compound, an alumoxane, or a compound which reacts with the bridged metallocene to form an ion pair; narrow molecular weight distribution. | MITSUI CHEMICALS, INC. (JP) | 2006-11-30 | — | — | US | disclosed |
| EP-1661921-A1 | Synthetic lubricating oil and lubricating oil composition thereof | Mitsui Chemicals, Inc. (JP) | 2006-05-31 | — | — | EP | disclosed |
| EP-1640385-A2 | Process for preparing low molecular weight olefin (co)polymer and polymerizing catalyst used therefor | MITSUI CHEMICALS, INC. (JP) | 2006-03-29 | — | — | EP | disclosed |
| US-20050131171-A1 | Process for preparing low molecular weight olefin (CO) polymer and polymerization catalyst used therefor | MITSUI CHEMICALS, INC. (JP) | 2005-06-16 | — | — | US | disclosed |
| EP-1416000-A1 | Process for preparing low molecular weight olefin (co)polymer and polymerizing catalyst used therefor | Mitsui Chemicals, Inc. (JP) | 2004-05-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050131171-A1 | Process for preparing low molecular weight olefin (CO) polymer and polymerization catalyst used therefor | CYP4F11, WEE2, FAR1 | HTT 4436/4885DNM1 1191/4885L3MBTL1 1712/4885 |
| US-20250333427-A1 | Ligand Compound, Organic Chromium Compound, and Catalyst Composition Including the Same | OXER1, ORC3, CRKL | HTT 3757/4885DNM1 3351/4885L3MBTL1 3769/4885 |
| US-20250381558-A1 | Ligand Compound, Organic Chromium Compound, and Catalyst Compositions Containing the Same | EXOC1, OXER1, ORC3 | HTT 3482/4885DNM1 2962/4885L3MBTL1 3994/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.